Special considerations in interpreting liver function tests

American Family Physician

Volumn 59, Issue 8, 1999, Pages 2223-2230

  Johnston, David E ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; AMINOTRANSFERASE; AMMONIA; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; CHOLECYSTITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; HUMAN; LIVER DISEASE; LIVER FUNCTION TEST; PREOPERATIVE EVALUATION; PROTHROMBIN TIME;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; HUMANS; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; SEVERITY OF ILLNESS INDEX;

EID: 0033561303     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Kaplan MM. Laboratory tests. In: Schiff L, Schiff ER, eds. Diseases of the liver. 7th ed. Philadelphia: Lippincott, 1993:108-44.
2. Kamath PS. Clinical approach to the patient with abnormal liver function test results. Mayo Clin Proc 1996;71:1089-94.
3. Theal RM, Scott K. Evaluating asymptomatic patients with abnormal liver function test results. Am Fam Physician 1996;53:2111-9.
4. Goddard CJ, Warnes TW. Raised liver enzymes in asymptomatic patients: investigation and outcome. Dig Dis 1992;10:218-26.
5. Quinn PG, Johnston DE. Detection of chronic liver disease: costs and benefits. Gastroenterologist 1997;5:58-77.
6. Healey CJ, Chapman RW, Fleming KA. Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transaminases. Gut 1995;37:274-8.
7. Haber MM, West AB, Haber AD, Reuben A. Relationship of aminotranferases to liver histological status in chronic hepatitis C. Am J Gastroenterol 1995;90:1250-7.
8. Helfgott SM, Karlson E, Beckman E. Misinterpretation of serum transaminase elevation in "occult" myositis. Am J Med 1993;95:447-9.
9. Sherman KE. Alanine aminotransferase in clinical practice. Arch Intern Med 1991;151:260-5.
10. Carter-Pokras OD, Najjar MF, Billhymer BF, Shulman IA. Alanine arninotransferase levels in Hispanics. Ethnic Dis 1993;3:176-80.
11. Manolio TA, Burke GL, Savage PJ, Jacobs DR Jr, Sidney S, Wagenknecht LE, et al. Sex-and race-related differences in liver-associated serum chemistry tests in young adults in the CARDIA study. Clin Chem 1992;38:1853-9.
12. Salvaggio A, Periti M, Miano L, Tavanelli M, Marzorati D. Body mass index and liver enzyme activity in serum. Clin Chem 1991;37:720-3.
13. Palmer M, Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology 1990;99:1408-13.
14. Vajro P, Lofrano MM, Fontanella A, Fortunato G. Immunoglobulin complexed AST ("macro-AST") in an asymptomatic child with persistent hypertransaminasemia. J Pediatr Gastroenterol Nutr 1992;15:458-60.
15. Yasuda K, Okuda K, Endo N, Ishiwatari Y, Ikeda R, Hayashi H, et al. Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal. Gastroenterology 1995;109:1295-300.
16. Gitlin N, Serio KM. Ischemic hepatitis: widening horizons. Am J Gastroenterol 1992;87:831-6.
17. Cohen JA, Kaplan MM. The SGOT/SGPT ratio - an indicator of alcoholic liver disease. Dig Dis Sci 1979;24:835-8.
18. Diehl AM, Potter J, Boitnott J, Van Duyn MA, Herlong HF, Mezey E. Relationship between pyridoxal 5′-phosphate deficiency and aminotransferase levels in alcoholic hepatitis. Gastroenterology 1984;86:632-6.
19. Greenwood SM, Leffler CT, Minkowitz S. The increased mortality rate of open liver biopsy in alcoholic hepatitis. Surg Gynecol Obstet 1972; 134:600-4.
20. Whitfield JB, Pounder RE, Neale G, Moss DW. Serum gamma-glutamyl transpeptidase activity in liver disease. Gut 1972;13:702-8.
21. Whitehead TP, Clarke CA, Whitfield AG. Biochemical and hematological markers of alcohol intake. Lancet 1978;1(8071):978-81.
22. Keeffe EB, Sunderland MC, Gabourel JD. Serum gamma-glutamyl transpeptidase activity in patients receiving chronic phenytoin therapy. Dig Dis Sci 1986;31:1056-61.
23. Mendis GP, Gibberd FB, Hunt HA. Plasma activities of hepatic enzymes in patients on anticonvulsant therapy. Seizure 1993;2:319-23.
24. Lieberman D, Phillips D. "Isolated" elevation of alkaline phosphatase: significance in hospitalized patients. J Clin Gastroenterol 1990;12:415-9.
25. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 1995;333:1171-5.
26. Westwood A. The analysis of bilirubin in serum. Ann Clin Biochem 1991;28:119-30.
27. Rothschild MA, Oratz M, Schreiber SS. Serum albumin. Hepatology 1988;8:385-401.
28. Basile AS, Jones EA. Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy. Hepatology 1997;25:1303-5.
29. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.
30. Villeneuve JP, Infante-Rivard C, Ampelas M, Pomier-Layrargues G, Huet PM, Marleau D. Prognostic value of the aminopyrine breath test in cirrhotic patients. Hepatology 1986;6:928-31.
31. Garrison RN, Cryer HM, Howard DA, Polk HC Jr. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg 1984;199:648-55.
32. Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997;112:463-72.